Evaxion Biotech A/S
EVAX
$1.65
$0.063.77%
NASDAQ
| 12/31/2023 | 12/31/2023 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.34% | 20.34% | 20.34% | -- | -- |
| Total Depreciation and Amortization | -42.50% | -42.50% | -42.50% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.40% | 27.40% | 27.40% | -- | -- |
| Change in Net Operating Assets | 357.98% | 357.98% | 357.98% | -- | -- |
| Cash from Operations | 54.28% | 54.28% | 54.28% | -- | -- |
| Capital Expenditure | 101.54% | 101.54% | 101.54% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 101.54% | 101.54% | 101.54% | -- | -- |
| Total Debt Issued | -100.00% | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | 0.84% | 0.84% | 0.84% | -- | -- |
| Issuance of Common Stock | 1,874.68% | 1,874.68% | 1,874.68% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 58,475.00% | 58,475.00% | 58,475.00% | -- | -- |
| Cash from Financing | 5,377.08% | 5,377.08% | 5,377.08% | -- | -- |
| Foreign Exchange rate Adjustments | -77.92% | -77.92% | -77.92% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.99% | 165.99% | 165.99% | -- | -- |